GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FIT Biotech Oy (OHEL:FITBIO) » Definitions » Net Interest Income

FIT Biotech Oy (OHEL:FITBIO) Net Interest Income : €-0.46 Mil (TTM As of Jun. 2018)


View and export this data going back to 2015. Start your Free Trial

What is FIT Biotech Oy Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. FIT Biotech Oy's net interest income for the six months ended in Jun. 2018 was €-0.06 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2018 was €-0.46 Mil.

FIT Biotech Oy Net Interest Income Historical Data

The historical data trend for FIT Biotech Oy's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FIT Biotech Oy Net Interest Income Chart

FIT Biotech Oy Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17
Net Interest Income
-0.04 -0.01 -1.23 -0.62 -0.46

FIT Biotech Oy Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18
Net Interest Income Get a 7-Day Free Trial Premium Member Only - -0.62 -0.06 -0.40 -0.06

FIT Biotech Oy Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2018 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FIT Biotech Oy Net Interest Income Related Terms

Thank you for viewing the detailed overview of FIT Biotech Oy's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

FIT Biotech Oy Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FIT Biotech Oy (OHEL:FITBIO) » Definitions » Net Interest Income
Comparable Companies
GNBT AURX XSAT:INIT OSTO:CMOTEC B TSXV:PBS XSAT:SLOTT B LSE:AOR NEXS TSXV:VXL OSTO:BAYN XSAT:PMED CAPS BTHE TIKRF TSXV:ICO ASX:ACL MNTM TSXV:MFS ENTB WAR:PFM
Traded in Other Exchanges
N/A
Address
Biokatu 12, Tampere, FIN, FI-33520
Website
http://www.fitbiotech.com
FIT Biotech Oy is a clinical-stage biotechnology company. It is primarily focused on developing antibody therapies for cancer immunotherapy as well as Deoxyribonucleic acid (DNA) vaccines for the prevention of infectious diseases such as Human immunodeficiency virus (HIV). The firm's GTU technology enables the production of antibodies in the human body instead of using industrially manufactured antibodies. The GTU technology platform has various application areas. The group generates revenue through the sales of services related to the HIV vaccine. The organization is based in Finland.

FIT Biotech Oy Headlines

No Headlines